Exicom Tele-Systems Extends R&D IPO Fund Deadline to Sept 2026

TECH
Whalesbook Corporate News Logo
AuthorAnanya Iyer|Published at:
Exicom Tele-Systems Extends R&D IPO Fund Deadline to Sept 2026
Overview

Exicom Tele-Systems' board has approved extending the deadline for using unspent IPO funds for Research & Development (R&D). About ₹8.83 crore will now be spent on R&D activities by September 30, 2026. This change follows delays in product development, suggesting a revised innovation plan.

Instant Stock Alerts on WhatsApp

Used by 10,000+ active investors

1

Add Stocks

Select the stocks you want to track in real time.

2

Get Alerts on WhatsApp

Receive instant updates directly to WhatsApp.

  • Quarterly Results
  • Concall Announcements
  • New Orders & Big Deals
  • Capex Announcements
  • Bulk Deals
  • And much more

Exicom Tele-Systems Extends IPO Fund Deadline for R&D to September 2026

Exicom Tele-Systems will have more time to spend unutilized IPO funds on Research & Development (R&D). The company's Board of Directors approved extending the deadline for deploying approximately ₹8.83 crore towards R&D activities. The new deadline is September 30, 2026.

This decision was made during the Board of Directors meeting on March 26, 2026. The extension addresses delays encountered in the company's R&D initiatives and product development cycles. As of December 31, 2025, Exicom had utilized ₹381.34 crore of its IPO allocation for stated objectives. An additional ₹9.18 crore was deployed in the fourth quarter of the 2025-26 fiscal year. The total IPO allocation for these objectives was ₹400 crore.

For Exicom Tele-Systems, operating in rapidly evolving sectors like electric vehicle (EV) charging and telecom power solutions, R&D is crucial. Successful innovation drives new products, boosts efficiency, and maintains a competitive edge. Delays in deploying these specific R&D funds could influence the pace of new product launches and technological advancements.

Exicom Tele-Systems, founded in 1994, raised ₹429 crore through its Initial Public Offering (IPO) in February 2024. The IPO proceeds were designated for capital expenditure, debt repayment, working capital, and R&D. The company had previously received an extension for utilizing IPO funds until March 31, 2026, due to project completion lags and external factors.

The main adjustment is the extended timeline for spending the remaining ₹8.83 crore of IPO funds specifically on R&D, now set for September 30, 2026. The overall goals for the IPO proceeds remain the same; only the deployment schedule for this portion of R&D funds has been revised.

However, several risks accompany these developments. Delays in R&D and product development, potentially influenced by external collaborations or the timeline for EV product rollouts, could impact future market entries. Execution risks related to project completion are also present, as previously indicated by delays in manufacturing facility construction and working capital deployment. Furthermore, Exicom's Critical Power segment heavily relies on its top five customers, creating a risk if these relationships weaken. Losses from its acquired subsidiary, Tritium, have continued to be a significant drag on consolidated financials and liquidity, according to CARE Ratings.

In the EV charging market, where Exicom holds significant positions (60% in residential and 25% in public segments as of FY24), it faces strong competition. Peers such as Tata Power, ABB India, and Delta Electronics are also heavily investing in technology and infrastructure expansion, underscoring the need for Exicom to efficiently deploy its R&D funds to remain competitive.

Recent financial performance provides context. For the full year ended March 31, 2025, Exicom Tele-Systems reported a consolidated net loss of ₹110.03 crore on sales of ₹867.61 crore. In the quarter ended March 31, 2025, the company posted a consolidated net loss of ₹62.28 crore, with sales at ₹265.52 crore.

Looking ahead, investors will monitor Exicom's progress in deploying the remaining ₹8.83 crore for R&D by the new September 30, 2026 deadline. The company's success in bringing new technologies to market and its overall financial health, including managing subsidiary losses and improving profitability, will also be key areas of focus. Any further announcements regarding fund utilization and project timelines will be closely watched.

Get stock alerts instantly on WhatsApp

Quarterly results, bulk deals, concall updates and major announcements delivered in real time.

Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.